JXHGF(JXHGF)
JXHGF
No analyst ratings available
No analyst price targets available for JXHGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $12.95T | $12.19T | $12.23T | $12.12T | $11.36T |
| Low | $12.09T | $11.75T | $11.59T | $11.49T | $10.77T |
| High | $13.64T | $13.54T | $13.22T | $13.10T | $12.28T |
| EBITDA Avg | $789.47B | $743.29B | $745.44B | $738.78B | $692.38B |
| Low | $737.03B | $716.26B | $706.92B | $700.60B | $656.60B |
| High | $831.46B | $825.39B | $806.03B | $798.83B | $748.66B |
| EBIT Avg | $438.78B | $413.11B | $414.31B | $410.60B | $384.82B |
| Low | $409.63B | $398.09B | $392.90B | $389.39B | $364.93B |
| High | $462.11B | $458.74B | $447.98B | $443.98B | $416.10B |
| Net Income Avg | $386.22B | $307.29B | $362.87B | $353.98B | $324.04B |
| Low | $360.27B | $286.64B | $338.50B | $330.20B | $302.28B |
| High | $427.03B | $339.76B | $401.22B | $391.38B | $358.29B |
| EPS Avg | $143.31 | $114.02 | $134.64 | $131.34 | $120.24 |
| Low | $133.68 | $106.36 | $125.60 | $122.52 | $112.16 |
| High | $158.45 | $126.07 | $148.87 | $145.22 | $132.94 |
| Analysts (Rev / EPS) | 8 / 1 | 7 / 1 | 5 / 1 | 3 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $3.51T | $3.46T | $3.45T |
| Low | $3.03T | $2.98T | $2.98T |
| High | $4.00T | $3.93T | $3.93T |
| EBITDA Avg | $214.29B | $210.71B | $210.50B |
| Low | $184.82B | $181.73B | $181.55B |
| High | $243.76B | $239.68B | $239.45B |
| EBIT Avg | $119.10B | $117.11B | $116.99B |
| Low | $102.72B | $101.00B | $100.90B |
| High | $135.48B | $133.21B | $133.08B |
| Net Income Avg | $30.60B | $34.09B | $-2.42B |
| Low | $25.13B | $28.00B | $-2.85B |
| High | $36.08B | $40.19B | $-1.98B |
| EPS Avg | $11.36 | $12.65 | $-0.90 |
| Low | $9.33 | $10.39 | $-1.06 |
| High | $13.39 | $14.91 | $-0.74 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |